How the LDT Final Rule’s Exemptions Apply to Oncology Labs
Regulatory expert explores whether any exclusions might benefit cancer laboratories trying to navigate upcoming compliance deadlines
Regulatory expert explores whether any exclusions might benefit cancer laboratories trying to navigate upcoming compliance deadlines
Could not following MAC guidance constitute evidence that a party knowingly submitted, or caused the submission of, false claims?
There are potentially significant legal ramifications of employing digital nomads who work from abroad—for both you and your employee.
What labs and billing managers need to know about multianalyte assays with algorithmic analyses coding for tests based on molecular platforms.
The court recently denied the petition to hear a case that would have helped offer clarity on what evidence whistleblowers need to file qui tam lawsuits under the FCA.
The US has taken its first steps to establish legal limits over AI use by publishing a voluntary code to ensure responsible corporate use of AI.
With temporary waivers of restriction relating to telehealth likely to end soon, here’s a roundup of the current state of state telehealth licensing law.
The final Outpatient Prospective Payment System Final Rule for 2023 provides for a rate increase of nearly four percent.
Despite Congress’ clear policy on private insurer payment of COVID-19 tests, many labs have been struggling to get reimbursed.
Solutions you can implement right away to address current lab staffing concerns and prepare for the future.
Increasing incidences of heart disease, as well as technological advances, will drive growth over the next eight to 10 years, reports say.